Cargando…
Muscle-specific microRNAs as biomarkers of Duchenne Muscular Dystrophy progression and response to therapies
Recent studies have revealed the contribution of fibro-adipogenic progenitors (FAPs) to the pathogenesis and progression of Duchenne Muscular Dystrophy (DMD). While FAPs direct compensatory regeneration at early stages of disease, as the disease progresses they contribute to the progressive replacem...
Autores principales: | Giordani, L, Sandoná, M, Rotini, A, Puri, PL, Consalvi, S, Saccone, V |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4755242/ https://www.ncbi.nlm.nih.gov/pubmed/26942105 http://dx.doi.org/10.4161/21675511.2014.974969 |
Ejemplares similares
-
The immune system in Duchenne muscular dystrophy: Friend or foe
por: Villalta, S Armando, et al.
Publicado: (2015) -
Simvastatin offers new prospects for the treatment of Duchenne muscular dystrophy
por: Whitehead, Nicholas P., et al.
Publicado: (2016) -
Drosophila as a starting point for developing therapeutics for the rare disease Duchenne Muscular Dystrophy
por: Pantoja, Mario, et al.
Publicado: (2013) -
Longitudinal Study of Three microRNAs in Duchenne Muscular Dystrophy and Becker Muscular Dystrophy
por: Trifunov, Selena, et al.
Publicado: (2020) -
Facioscapulohumeral muscular dystrophy: Are telomeres the end of the story?
por: Stadler, Guido, et al.
Publicado: (2013)